Induction of Apoptosis using Gene Therapy in the Treatment of Cancer
DOI:
https://doi.org/10.37591/rrjooh.v2i3.1465Abstract
Gene therapy is the treatment of a genetic disease through the insertion of normal or genetically altered genes into cells in order to replace or make up for the non-functional or missing genes. A major application of gene therapy is the induction of apoptosis to inhibit metastases or cure cancer. Besides the identification of the target site, the choice of a suitable vector system for gene delivery is also critical for the realization of gene therapy. While ribozyme mediated induction of apoptosis has an advantage of maintaining regulated expression level of the endogenous gene, antisense therapy suffers a disadvantage of destruction of the oligonucleotides by DNase. The use of siRNA, a novel approach in the field of gene therapy, is limited by their degradation in blood and extracellular fluids. This review discusses the problems associated with the application of the established methods for treatment of cancer viz. surgery, chemotherapy, radiotherapy, and laser therapy. Further, the efficacy of the various strategies for the induction of apoptosis via antisense oligonucleotides, ribozyme, siRNA, and adenoviruses, based on clinical trials and experiments on animal models have been evaluated. Despite some success in this field, some challenges regarding the pathogenecity of viral vectors and transfection efficiency of non viral vectors still remains unanswered.
Keywords: Gene therapy, apoptosis, antisense oligonucleotides, siRNA, transfection
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
